The technology sector makes up just over a third of the S&P 500 with a 34% weighting. The tech sector includes the three ...

While the United States remains a major market due to advanced research and telemedicine adoption (CAGR: 4.5%), Asia-Pacific ...

European stocks fell Thursday as investors weighed ongoing concerns about the artificial-intelligence boom and data showing gains in business activity. The composite purchasing managers' index for the ...

RFK Jr. has his sights set on increasing oversight and enforcement against drugmakers that run afoul of advertising laws.

As the world’s population ages at an unprecedented rate, the field of longevity research is surging to the forefront of ...

Worker-led protests erupted at Microsoft headquarters this week as the tech company promises an “urgent” review of the ...

Eli Lilly & Co ( ($LLY) ) has provided an announcement. On August 18, 2025, Eli Lilly & Co entered into an underwriting ...

Meta’s plans to build a 1,500-acre data center in Lebanon’s LEAP Research and Innovation District continue to move forward ...

Eli Lilly is one of the top growing stocks at the moment. Learn the reasons why this might be a stock to consider.

Tier-two pharma picks show solid fundamentals, but Eli Lilly (LLY) stock stands out for its growth potential. Read here for ...

Viking Therapeutics' weight-loss pill trial results underwhelmed, causing a sharp decline in shares. Meanwhile, Novo Nordisk's liver disease approval for Wegovy uplifted its stock. European corporate ...

Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.